» Articles » PMID: 6671129

The Statistical Comparison of Relative Survival Rates

Overview
Journal Biometrics
Specialty Public Health
Date 1983 Dec 1
PMID 6671129
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

A statistical procedure for comparing the survival of two or more groups of patients adjusted for normal mortality expectation, i.e. for calculating relative survival, is proposed. The method is shown to correspond to some commonly used procedures for comparing unadjusted survival; it provides an improvement over these procedures in many situations, even when the normal mortality expectations for the patient groups are the same. An example of its use is given.

Citing Articles

Epidemiology, trends, and survival of ocular and orbital rhabdomyosarcoma: a nationwide study in the USA (1996-2018) : Ocular and orbital rhabdomyosarcoma in the USA.

Kunbaz A, Alfaar A Graefes Arch Clin Exp Ophthalmol. 2024; .

PMID: 39540909 DOI: 10.1007/s00417-024-06685-6.


Epidemiology and prognostic analysis of patients with pancreatic signet ring cell carcinoma: a population-based study.

Nie D, Lan Q, Huang Y, Fang C, Cao Y, Chen Y BMC Gastroenterol. 2022; 22(1):458.

PMID: 36384527 PMC: 9667582. DOI: 10.1186/s12876-022-02543-z.


Osteosarcoma: A Surveillance, Epidemiology, and End Results program-based analysis from 1975 to 2017.

Cole S, Gianferante D, Zhu B, Mirabello L Cancer. 2022; 128(11):2107-2118.

PMID: 35226758 PMC: 11647566. DOI: 10.1002/cncr.34163.


Relative survival after diagnosis with a primary brain or other central nervous system tumor in the National Program of Cancer Registries, 2004 to 2014.

Ostrom Q, Truitt G, Gittleman H, Brat D, Kruchko C, Wilson R Neurooncol Pract. 2020; 7(3):306-312.

PMID: 32537180 PMC: 7274192. DOI: 10.1093/nop/npz059.


The differences between gonadal and extra-gonadal malignant teratomas in both genders and the effects of chemotherapy.

Sun H, Ding H, Wang J, Zhang E, Fang Y, Li Z BMC Cancer. 2019; 19(1):408.

PMID: 31039746 PMC: 6492338. DOI: 10.1186/s12885-019-5598-0.